A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

Y. Hattori; W. Du; Taketo Yamada; D. Ichikawa; S. Matsunami; M. Matsushita

doi:10.1038/bcj.2013.13

A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

Y. Hattori, W. Du, Taketo Yamada, D. Ichikawa, S. Matsunami, M. Matsushita

School of Pharmacy

Research output: Contribution to journal › Letter › peer-review

7 Citations (Scopus)

Original language	English
Article number	e115
Journal	Blood cancer journal
Volume	3
Issue number	5
DOIs	https://doi.org/10.1038/bcj.2013.13
Publication status	Published - 2013 May

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/bcj.2013.13

Cite this

@article{85aa1096d65e4eb5beabedad2b463112,

title = "A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor",

author = "Y. Hattori and W. Du and Taketo Yamada and D. Ichikawa and S. Matsunami and M. Matsushita",

year = "2013",

month = may,

doi = "10.1038/bcj.2013.13",

language = "English",

volume = "3",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

AU - Hattori, Y.

AU - Du, W.

AU - Yamada, Taketo

AU - Ichikawa, D.

AU - Matsunami, S.

AU - Matsushita, M.

PY - 2013/5

Y1 - 2013/5

UR - http://www.scopus.com/inward/record.url?scp=84878336896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878336896&partnerID=8YFLogxK

U2 - 10.1038/bcj.2013.13

DO - 10.1038/bcj.2013.13

M3 - Letter

C2 - 23686003

AN - SCOPUS:84878336896

SN - 2044-5385

VL - 3

JO - Blood cancer journal

JF - Blood cancer journal

IS - 5

M1 - e115

ER -

A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this